Description: FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmic, vitamins, minerals, dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, and analgesics; and anti-oxidants, balanced energy and protein drinks, and vitamins and nutraceuticals, as well as various active pharmaceutical ingredients. It provides its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Vitcofol, Ziglim, Ziglim Plus 2, Electral, and Enerzal brand names. The company was founded in 1936 and is headquartered in Mumbai, India.
Home Page: www.fdcindia.com
C/3, Skyvistas
Mumbai,
400053
India
Phone:
91 24 0255 4407
Officers
| Name | Title |
|---|---|
| Dr. Nandan Mohan Chandavarkar | Joint MD & Executive Director |
| Mr. Mohan Anand Chandavarkar | BR Head, MD & Director |
| Mr. Ameya Ashok Chandavarkar | CEO of International Business & Executive Director |
| Mr. Ashok Anand Chandavarkar | Whole Time Director |
| Mr. Vijay Dharmadatt Bhatt | Chief Financial Officer |
| Mr. Lalit Aggarwal | President of Technical & Operations |
| Mr. Sanjay B. Jain | Vice President of Corporate Finance |
| Ms. Varsharani Rajaram Katre C.S. | Compliance Officer & Company Secretary |
| Mr. Shashank Vyapari | Associate Vice President of Technical & Operations |
| Mr. Anant Kharche | Associate Vice President of Engineering Services & Projects |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 26.3788 |
| Price-to-Book MRQ: | 3.6562 |
| Price-to-Sales TTM: | 4.0516 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 6659 |